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Dialysis vascular access planning, creation, and management is of critical impor-
tance to the dialysis patient population. It requires a multidisciplinary approach
involving patients and their families, dialysis facility staff, the nephrologist, the
surgeon, and the interventionalist. With the emergence of interventional nephrol-
ogy as a subspecialty of nephrology, the nephrologist is increasingly providing both
the nephrology and interventional aspects of care, and in some areas, the surgical
functions as well. Most of these interventional nephrologists work in freestanding
outpatient dialysis access centers (DACs). Large clinical studies published over the
past 10 years demonstrate that the interventional nephrologist can manage the
problems associated with dialysis access dysfunction effectively, safely, and eco-
nomically. A recently published study based upon United States Medicare claims
data in which a DAC patient group (n ¼ 27,613) and a hospital outpatient depart-
ment patient group (HOPD group; n ¼ 27,613) were compared using propensity
score matching techniques showed that patients treated in the DACs had signiﬁ-
cantly better clinical outcomes (Po0.001). This included fewer vascular access-
related infections (0.18 vs. 0.29), fewer septicemia-related hospitalizations (0.15 vs.
0.18), and a lower mortality rate (47.9% vs. 53.5%).
Copyright & 2015. The Korean Society of Nephrology. Published by Elsevier. This is an
open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Hemodialysis is the perfect example of bioengineering
being applied to a medical problem to preserve the life of
the patient with an otherwise fatal disease. Unfortunately, the
interface between the mechanism and the patient, the vascu-
lar access, is defective. It is a problem that contributes
signiﬁcantly to the morbidity and mortality associated with
the process and the leading cause of hospitalization in the
end-stage renal disease (ESRD) patient population [1]. Dialysis15. The Korean Society of Nep
.org/licenses/by-nc-nd/4.0/).
Houston, Texas 77056,
hard).vascular access planning, creation, and management are cri-
tical in allowing realization of the ESRD patient’s longevity
potential. This process is best carried out using a multidisci-
plinary approach which involves the patient and his/her
family, the nephrologist, the dialysis facility personnel, the
surgeon, and the interventionalist.
For healthcare professionals, regardless of their specialty, to
perform their function in this process in the most optimal
fashion, they should possess three critical characteristics [2].
First, they must understand the dialysis process and the
dialysis patient. Dialysis patients are unique and have unique
problems. Access planning, creation, and management must be
individualized. A single algorithm will not serve all cases.
Individualization is possible only through understanding of
the patient and the process.hrology. Published by Elsevier. This is an open access article under the
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in-depth knowledge of dialysis vascular access. This must
include the types of access that are available, the individual
characteristics of each, and the appropriate application of each.
This must include a knowledge of what not to do and what to
do in individual cases.
Third, they must have skill and expertise in the procedures
that they are to perform whether this be the cannulation of an
arteriovenous access, the surgical creation of the access, or a
maintenance procedure performed because of malfunction.
The nephrologist must play a leadership role in the multi-
disciplinary team overseeing dialysis vascular access. First and
foremost, the nephrologist caring for the patient on chronic
dialysis therapy has a responsibility to be an advocate for that
patient. To perform this function adequately and effectively, it
is essential that the physician become knowledgeable in the
area of vascular access, develop a vascular access strategy, and
oversee its operation. Delegation of this facet of dialysis
patient care to other specialists is less than optimum. The
physician who knows the most about the patient, is an expert
in hemodialysis, and has the deepest understanding of how
the vascular access impacts all other facets of the patient's care
must also be the leader in managing the vascular access.
It is possible for the nephrologist to play an active role in all of
the three activities associated with dialysis vascular access—plan-
ning, creation, or management—and in some areas, they do. An
increasing number of nephrologists have found that the best way
to fulﬁll their obligation to the patient is interventional nephrology
(IN). Historically, dialysis vascular access planning, creation, and
maintenance have not been done well in many parts of the world
[3–7]. Because of this, nephrologists have been becoming increas-
ingly involved over the past 2 decades. This is especially true for
dialysis access maintenance procedures. This has given rise to a
new subspecialty of nephrology referred to as IN.Interventional nephrology
In practice, although some would want to broaden the deﬁni-
tion, the term interventional nephrology has come to be deﬁned asFigure 1. Case distribution for IN facility. This is based on 100,000
procedures performed in 75 facilities for the year 2014.
Angio, angiogram; Cath, catheter-based procedures; Clin exam, clinical
examination; IN, interventional nephrology; Other, miscellaneous pro-
cedures; PTA, percutaneous transluminal angioplasty; Throm, throm-
bectomy; Vasc map, vascular mapping.that branch of nephrology that deals with the establishment and
maintenance of dialysis access, particularly arteriovenous access.
A tabulation of the variety of procedures performed in a typical
group of facilities is shown in Fig. 1. In the United States, most
interventional nephrologists work in freestanding dialysis access
centers (DACs), which are designed, equipped, staffed, and sup-
plied speciﬁcally for dialysis vascular access management proce-
dures. Their primary goal is to provide an efﬁcient and economical
alternative for managing access dysfunction away from the hospi-
tal setting. Their efﬁciency allows for a patient with a thrombosed
vascular access to receive therapy and return to the dialysis clinic
within a matter of hours, thus avoiding missed treatments.
The growth of IN has been almost exponential since its
beginning. All of the reasons for this growth are not obvious;
however, there are several advantages that relate to improved
patient care that have become apparent in dialysis programs in
which an interventional nephrologist is involved. The ﬁrst of
these is expeditious management of dialysis access dysfunc-
tion. Typically, dialysis access procedures have been given low
priority by consultants performing the required procedures. As
a result, patients require hospitalization and temporary dia-
lysis catheters frequently [1]. With the advent of IN, these have
become outpatient cases associated with a quickly realized,
marked decrease in dialysis patient hospitalization and missed
dialysis treatments [8].
A second advantage is individualized patient care. The
nephrologist trained as an interventionalist can provide the
required individualized care, and a prospective approach to
the planning for future dialysis vascular access can be provided
only by someone who understands the dialysis patient, the
dialysis treatment, and vascular access issues.
An additional advantage relates to the opportunity for
research and innovation that is offered by involvement in the
management of the dialysis patient's vascular access. Many
dialysis vascular access principles are opinion based. This
problem is of obvious paramount importance to the nephrol-
ogist providing care to these patients. The nephrologist who is
well versed in the basic principles of dialysis vascular access
and has the ability to manage these problems independently is
in an advantageous position to conduct meaningful research
and innovation in this area.Table 1. Success rates for dialysis access procedures for interven-
tional nephrologists
Procedure
2004 2014
No. Success rate (%) No. Success rate (%)
TDC-Place 1,765 98.24 4,038 97.89
TDC-Ex 2,262 98.36 8,851 99.29
AVF-PTA 1,561 96.58 32,392 99.40
AVG-PTA 3,560 98.06 12,418 99.56
AVF-T 228 78.10 2,613 87.94
AVG-T 4,671 93.08 8,447 94.08
Combined 14,067 96.18 68,759 98.24
AVF, arteriovenous ﬁstula; AVG, arteriovenous graft; Ex, exchange;
Place, placement; PTA, percutaneous transluminal angioplasty; T,
thrombectomy; TDC, tunneled dialysis catheter.
From “Effectiveness and safety of dialysis vascular access procedures
performed by interventional nephrologists,” by G.A. Beathard, T. Litch-
ﬁeld, Physician Operators Forum of RMS Lifeline, Inc., 2004, Kidney Int,
66, p. 1622–1632. Reprinted with permission.
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Dialysis patients represent a high-risk group for any type
of interventional procedure. Published reviews of serious
complications encountered in association with procedures
performed by interventional radiologists have shown that
hemodialysis access management procedures carried a greater
risk than other interventional vascular procedures which are
primarily arterial [9,10]. When the ﬁrst nephrologists began to
perform as interventionalists, a number of appropriate ques-
tions were raised—the quality of medical care provided, the
safety of sedation/analgesia (S/A) performed by nonanesthe-
siologists in an outpatient setting, the safety of radiation-based
procedures performed by nonradiologists, and the economic
impact of providing the services outside hospital setting. The
answers to these questions have been provided by a series of
studies reported over the past 10 years.
The ﬁrst of these was a study conducted to evaluate the
efﬁcacy and safety of dialysis access maintenance procedures
in the hands of trained nephrologists. In a retrospective cohort
study of 14,067 cases performed by 29 interventional nephrol-
ogists working in 11 freestanding DACs, a 96.18% clinical
success rate was recorded [11]. This study was based on
prospectively collected data maintained in an electronic med-
ical record and included six different procedures related toTable 2. Complication rates for dialysis access procedures for
interventional nephrologists
Procedure
2004 2014
No. Minor
(%)
Major
(%)
No. Minor
(%)
Major
(%)
TDC-Place 1,765 1.36 0.06 4,038 0.42 0.15
TDC-Ex 2,262 1.37 0.04 8,851 0.19 0.15
AVF-PTA 1,561 4.29 0.19 32,392 1.24 0.08
AVG-PTA 3,560 1.04 0.11 12,418 0.64 0.07
AVF-T 228 6.07 0.44 2,613 4.13 0.92
AVG-T 4,671 5.99 0.26 8,447 2.13 0.41
Combined 14,067 3.26 0.28 68,759 1.17 0.16
AVF, arteriovenous ﬁstula; AVG, arteriovenous graft; Ex, exchange;
Place, placement; PTA, percutaneous transluminal angioplasty; T,
thrombectomy; TDC, tunneled dialysis catheter.
From “Effectiveness and safety of dialysis vascular access procedures
performed by interventional nephrologists,” by G.A. Beathard, T. Litchﬁeld,
Physician Operators Forum of RMS Lifeline, Inc., 2004, Kidney Int, 66,
p. 1622–1632. Reprinted with permission.
Table 3. Comparison of dialysis access-related procedure complications
AV access procedures
Thrombectomy Angio/PTA
IR
(N ¼ 393)
IN
(N ¼ 11,789)
IR
(N ¼ 1,258)
IN
(N ¼ 50,300
CPA (%) 0.51 0.10 0.08 0.02
ME (%) 0.76 0.41 0.32 0.10
All (%) 1.27 0.51 0.40 0.11
AV, arteriovenous; Angio/PTA, combined angiogram and angioplasty gro
interventional radiology; ME, medical emergency.
From “Medical emergencies and cardiopulmonary arrests in interventional
Soulen, S.W. Stavropoulos, S.O. Trerotola, C. Farrelly, 2013, J Vasc Interv Rad
setting: risky?” by A.Q. Urbanes, 2013, J Vasc Interv Radiol, 24, p. 1787–1789dialysis vascular access management. The clinical success rate
and the size for each of these individual procedures were
tabulated separately and are shown in Table 1. These data are
reﬂective of the vascular access proﬁle of dialysis patients in
the period preceding 2004. Although the number of published
studies available for comparison with this report was some-
what limited, the success rate for these cases was equal or
superior to the results that were available at that time [11].
Table 1 also shows data for 2014 from this same DAC group,
expanded in number from 11 to 75 facilities. Over this 10-year
span, the success rate for all procedures continued to be at a high
level. It is obvious that a shift from arteriovenous graft to arterio-
venous ﬁstula (AVF) use occurred during this period. In addition,
the success of dealing with AVF thrombosis improved by 10%.
This study also addressed procedure-related complications
(PRCs) [11]. For the 14,067 cases studied, complications were
classiﬁed according to the (American) Society of Interventional
Radiology complication classiﬁcation system [12,13]. According to
this system, complications are classiﬁed as none, minor, or major.
In a general sense, minor complications are those that have no
permanent sequelae and require no speciﬁc therapy. Major
complications are those that require a change in medical manage-
ment or have permanent sequelae. Complication rate thresholds
have also been established. In this series of patients, the PRC rates
(Table 2) were below the Society of Interventional Radiology
thresholds and were less than those previously published from
other, but smaller studies. Table 2 also shows data for 2014 from
this same DAC group, expanded in number from 11 to 75 facilities.
In addition to reﬂecting the changes brought about by evolving
from primarily synthetic grafts to primarily AVFs, the PRC rates
are even lower, especially for arteriovenous thrombectomies.
In a more recent report, a review of serious complications
occurring in a cohort of 84,669 hemodialysis access procedures
performed by interventional nephrologists in freestanding
DACs (IN group) was presented [14] compared with a con-
current report from an interventional radiology (IR) group [9].
This was from a hospital-based program and included data on
38,927 procedures, 4,132 of which were dialysis access related
(IR group). Serious complications were characterized as either
a medical emergency (ME) or a cardiopulmonary arrest (CPA).
For the purposes of this report, an ME was deﬁned as any
change in cardiovascular status or mentation that required the
patient to receive a higher-than-planned level of care, includ-
ing, but not limited to, transfer to the hospital. A CPA was
deﬁned as a state of cardiac or pulmonary activity requiring
initiation of an advanced cardiac life support protocol orCatheter
Total
)
IR
(N ¼ 1,651)
IN
(N ¼ 62,089)
IR
(N ¼ 2,088)
IN
(N ¼ 22,580)
0.18 0.03 0.29 0.01
0.42 0.16 0.24 0.08
0.61 0.19 0.53 0.09
ups; CPA, cardiopulmonary arrest; IN, interventional nephrology; IR,
radiology,” by G. Nadolski, A. Praestgaard, R.D. Shlansky-Goldberg, M.C.
iol, 24, p. 1779–1785 and “Dialysis access procedures in the outpatient
. Reprinted with permission.
Table 4. Complications related to S/A
Group No. (%) Minor Major S/A related
High risk 5,415 (42) 181 (1.40) 57 (0.44) 11 (0.085)
Lower risk 7,481 (58) 123 (0.96) 10 (0.08) 6 (0.046)
Total 12,896 304 (2.36) 67 (0.52) 17 (0.131 )
Data are expressed as n (%).
S/A, sedation/analgesia.
From “The risk of sedation/analgesia in hemodialysis patients under-
going interventional procedures” by G.A. Beathard, A. Urbanes, T.
Litchﬁeld, A. Weinstein, 2011, Semin Dial, 24, p. 97–103. Reprinted with
permission (Copyright - 2013. Copy right holder - Seminars in Dialysis).
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and CPA for arteriovenous access interventions (angioplasty
and thrombectomy) was reported in this IR group (Table 3),
whereas IN group data showed a frequency of 0.19%. The IR
group had a rate of 0.53% for ME and CPA for dialysis catheter
procedures, whereas the IN group showed a rate of 0.09%.
Pain management through effective S/A is important in
the performance of dialysis access maintenance procedures.
However, this aspect of management carries with it a degree of
risk, especially considering the ages and comorbidities of the
dialysis patient population. To address the question as to
whether an interventional nephrologist can administer S/A
safely in the outpatient setting, data derived from a cohort of
12,896 hemodialysis patients undergoing dialysis access main-
tenance procedures performed by interventional nephrologists
were analyzed to determine the safety of S/A drug adminis-
tration in a freestanding DAC [15]. In this study, all medications
were administered by the nephrologist performing the proce-
dure who had speciﬁc training in S/A. Intravenous midazolam,
fentanyl, or a combination of both was used. The S/A goal
was moderate sedation as deﬁned by the American Society
of Anesthesiology (ASA) [16] in all patients. All patients were
evaluated and monitored during the procedure according
to ASA guidelines. All drug dosages were individualized and
administered in small, incremental doses that were titrated
to the patient's response. Doses were adjusted to account
for patient size, age, and comorbidities at the physician's
discretion.
All dialysis patients are considered to be at higher risk than
normal for these types of procedures; however, within the
cohort, an especially high-risk group was identiﬁed. The
remainder of the cases were grouped together as the lower
risk group. The total (all types) complication rate in this cohort
of patients was 2.9%, of which 2.4% were minor complications.
Complications felt to be directly related to S/A were 0.13% (17
cases). Two-thirds of these occurred in the high-risk group
(Table 4). Two deaths occurred, but at a time remote from the
procedure and not felt to be related to the procedure (The
duration of the complication monitoring period is 30 days).
The conclusion of this study was that S/A administered for
these types of procedures by interventional nephrologists is a
safe procedure even in very high-risk patients.
Interventional procedures performed for dialysis vascular
access management require the use of ﬂuoroscopy. Any time
when radiological equipment is used by a nonradiologist, there
are legitimate concerns about radiation exposure to the
patient and healthcare team [17,18]. The effects of radiation
are cumulative. Most dialysis patients require repetitive pro-
cedures that are generally ﬂuoroscopy guided. Mostinterventional nephrologists and the staff of the DAC spend a
major portion of their work time in the procedure room and
anticipate doing so for a number of years. Therefore, radiation
safety must be of concern.
To analyze this issue as it relates to the interventional
nephrologist, a study was conducted to assess the levels of
radiation dosage involved with these procedures [19]. Dosi-
metry information including dose–area product (DAP), refer-
ence point air kerma (RPAK), and ﬂuoroscopy time was
collected prospectively. Radiation dosage data were collected
from 24 centers in various parts of the United States and
reﬂected cases managed by 69 different interventional
nephrologists. The data were tabulated separately for eight
procedures—ﬁstula angioplasty and thrombectomy, graft
angioplasty and thrombectomy, tunneled catheter placement
and exchange, as well as vein mapping and cases in which only
angiographic evaluation was performed. The number of cases
involved for each of these varied. The results are shown in
Table 5 as the number of cases reviewed for each procedure
and each metric and the geometric mean (the distribution was
non-Gaussian) for the group.
Biologic effects resulting from radiation exposure are tra-
ditionally divided into stochastic effects (primarily cancer
induction) and deterministic effects (primarily skin injury)
[20]. The radiation dose metric used to assess stochastic risk
is DAP. Assuming a normal life expectancy, it has been
estimated that this risk of experiencing a fatal malignancy is
increased 0.5% for each 100 mGy of effective dose of x-ray
radiation [21]. The DAP values listed in Table 5 are in Gy  cm2
(radiation dose in gray multiplied by area exposed in square
centimeter). It is not possible to convert this information directly
into effective dose of radiation; however, the values listed
represent a minuscule stochastic risk.
Deterministic effects are characterized by a threshold dose
below which they do not occur. In much the same way as
sunburn resulting from sun exposure, deterministic effects do
not occur until the dose threshold is reached, and then, their
severity increases from that point onward. The threshold for
the earliest skin changes, erythema, has been established at 2
Gy [22]. The radiation dose metric used to assess deterministic
risk is RPAK. The RPAK values listed in Table 5 are in milligray
with the highest value for any of the eight procedures being
6.4 mGy for arteriovenous graft thrombectomy. At this level, it
would require more than 300 procedures to produce skin
erythema provided that the ﬂuoroscopy machine was not
moved at any time during the procedures.
Very little has been published in the literature concerning
radiation dosage associated with dialysis vascular access
maintenance procedures. Comparisons with the studies that
are available are published by radiologists working in a
hospital setting [23–25]. These show a 3–8 greater radiation
dose than in this study. It should be recognized that some of
the decrease in dosage is related to the fact that interventional
nephrologists working in DAC use a mobile C-arm, whereas
those in a hospital setting generally use a ﬁxed C-arm ﬂuoro-
scopy unit. The dose levels are considerably lower with a
mobile C-arm because of the way it operates [26,27].Clinical value of IN
The vascular access of a dialysis patient is prone to
recurrent problems. It is important that these problems be
Table 5. Radiation dosages for procedures performed by interventional nephrologists
Metric AVF-PTA AVF-T AVG-PTA AVG-T Angio Cath-Place Cath Ex Map
FT (s) Geo. mean 54.3 90 47.7 88.3 30 24.6 22 50
n 6,126 513 2,876 2,098 1,808 810 2,043 978
RPAK (mGy) Geo. mean 2.21 4.60 2.14 5.35 1.08 0.69 1.08 2.02
n 168 24 126 40 36 44 78 46
DAP (Gy cm2) Geo. mean 0.741 0.873 0.798 0.903 0.590 0.832 0.892 1.142
n 6,128 513 2,876 2,098 1,808 810 2,043 978
Angio, angiogram; AVF, arteriovenous ﬁstula; AVG, arteriovenous graft; Cath, tunneled dialysis catheter; DAP, dose–area product; Ex, exchange; FT,
ﬂuoroscopy time; Geo. mean, geometric mean; Map, vein mapping; n, number of cases in group; Place, placement; PTA, percutaneous transluminal
angioplasty; RPAK, reference point air kerma; T, thrombectomy.
From “Radiation dose associated with dialysis vascular access interventional procedures in the interventional nephrology facility,” by G.A. Beathard,
A. Urbanes, T. Litchﬁeld, 2013, Semin Dial, 26, p. 503–510. Reprinted with permission (Copyright - 2013. Copy right holder - Seminars in Dialysis).
Figure 2. Clinical value and economy of DACs. Scale is relative, see the text for actual values; for all values, Pr0.01.
DAC, dialysis access center; HOPD, hospital outpatient department.
From “Clinical and economic value of performing dialysis vascular access procedures in a freestanding ofﬁce-based center as compared with the
hospital outpatient department among Medicare ESRD beneﬁciaries,” by A. Dobson, A.M. El-Gamil, M.T. Shimer, J.E. DaVanzo, A.Q. Urbanes, G.A.
Beathard, T.F. Litchﬁeld, 2013, Semin Dial, 26, p. 624–632. Reprinted with permission (Copyright - 2013. Copy right holder - Seminars in Dialysis).
Beathard / Role of interventional nephrology in HD 129managed effectively, efﬁciently, and timely. Not infrequently,
there is an emergent situation that requires an emergent
solution, deﬁned as the absence of a functioning access for
hemodialysis in a patient requiring emergent hemodialysis.
The goal of dialysis access management should be to avoid
missed dialysis treatments and avoid hospitalization. The
effectiveness and safety issues discussed previously speak to
the clinical value of IN; however, there are also published
reports that address the overall value of an IN program
working in a freestanding DAC.
Using retrospective data, a study was conducted to compare
hospitalization and missed dialysis treatment rates between
two patient populations—a test group consisting of a cohort of
approximately 6,000 patients receiving dialysis access man-
agement at an IN-operated facility and a control group con-
sisting of a national cohort of approximately 290,000 patients
[8]. This study looked at a period of 7 years. IN involvement
was initiated during the 4th year allowing for a comparison of
data within the test group representing a period before and
after the initiation of IN involvement. During the ﬁrst 3 years
of the study period, there was no signiﬁcant difference
between the test and control groups. However, with theinitiation of IN in the test group, both metrics, hospitalization
and missed dialysis treatment rates, declined markedly. By the
end of the study period, hospitalization days/patient year
decreased 57% in the test group and missed dialysis treat-
ments/patient year decreased 29% in comparison with the
control group (P ¼ 0.01).
The clinical value of interventional nephrologist working in
a DAC was further demonstrated by a prospective study
designed to evaluate the efﬁciency and outcomes of emergent
hemodialysis access procedures over a 3-month period in a
high-volume facility [28]. A total of 157 emergent procedures
were performed during the period of the study. The procedure
was successful in 95% of the cases with 90% being completed
within 24 hours of referral. Dialysis treatment was performed
within 24 hours in 61% of the cases and within 48 hours in an
additional 29%.
To evaluate the overall clinical effect of a DAC, US Medicare
claims data were collected representing incident and prevalent
ESRD patients who received at least 80% of their dialysis
vascular access management at either a DAC or a hospital
outpatient department over a 4-year period [29]. Using pro-
pensity score matching techniques [30], cases with a similar
Kidney Res Clin Pract 34 (2015) 125–131130clinical and demographic proﬁle from these two sites of
service were matched according to 47 different variables.
Medicare utilization, payments, and patient outcomes were
compared across the matched cohorts. This created a DAC
group (n ¼ 27,613) and an hospital outpatient department
(HOPD) group (n ¼ 27,613) for comparisons. Patients treated
in the DAC (Fig. 2) had signiﬁcantly better clinical outcomes
(Pr0.001). This included fewer vascular access-related infec-
tions (0.18 vs. 0.29) and fewer septicemia-related hospitaliza-
tions (0.15 vs. 0.18). Mortality rate was lower (47.9% vs. 53.5%).
Although this study was not able to make direct evaluations
based on medical specialty, the data did indicate that inter-
ventional nephrologists were more likely and interventional
radiologists were less likely to be providing most of the
patients' dialysis vascular access–related care in the DAC than
in an HOPD.
The Medicare claims data–based study discussed previously
also examined the economic value of a freestanding DAC
(Fig. 2). This study showed that matched patients treated in
the DAC had fewer dialysis vascular access procedures than
those treated in the HOPD (20.5 vs. 23.9, Pr0.01), fewer all-
cause hospital admissions (2.3 vs. 2.8, Pr0.001), fewer cathe-
ters placed (1.3 vs. 2.0, Pr0.001), and fewer stents placed (0.6
vs. 1.4, Pr0.001) despite having longer episodes and lower
mortality rates.
Matched patients who received their care in a freestanding
DAC had an average Medicare per member-per month pay-
ment for dialysis vascular access services that was $626 lower
than those who received care in the HOPD ($3,162 vs. $3,788;
conﬁdence interval, –$736 to –$516; Pr0.001). This repre-
sented a savings of $7,012 per patient per year or almost $200
million per year for the total cohort of 27,613 patients studied.Summary
Over the course of the past 20 years, IN has developed as a
subspecialty of nephrology specializing in the management of
dialysis vascular access problems. Working primarily in free-
standing, dedicated dialysis access facilities, interventional
nephrologists have demonstrated an ability to provide effec-
tive, safe, and economical interventional vascular access man-
agement care to the dialysis patient population which they
serve. IN has grown to the point that today it is providing most
of these essential medical services in many parts of the world.Conﬂicts of interest
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